Cargando…
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
Real-world evidence (RWE) plays an important role in the management of type 2 diabetes (T2D). It provides data about the effectiveness and safety of an intervention from outside the randomised controlled trial (RCT) setting and allows healthcare professionals (HCPs) to determine if RCT data are appl...
Autores principales: | Khunti, Kamlesh, Almalki, Mussa, Chan, Juliana C. N., Amod, Aslam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499769/ https://www.ncbi.nlm.nih.gov/pubmed/37603144 http://dx.doi.org/10.1007/s13300-023-01458-6 |
Ejemplares similares
-
Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives
por: Khunti, Kamlesh, et al.
Publicado: (2020) -
Introduction: Real-World Evidence in Type 2 Diabetes
por: Hassanein, Mohamed, et al.
Publicado: (2020) -
Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN
por: Hassanein, Mohamed, et al.
Publicado: (2021) -
Real-world evidence for regulatory decision-making: updated guidance from around the world
por: Burns, Leah, et al.
Publicado: (2023) -
Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
por: Cave, Alison, et al.
Publicado: (2019)